Sky Vision Pharma Private Limited - Company Profile

It is a manufacturing private limited company based in Indore, Madhya Pradesh, India, established in 2021.
2021 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Sky Vision Pharma Private Limited

Sky Vision Pharma Private Limited, a active private limited company, was established on 08 February 2021 in Indore, Madhya Pradesh, India. Engaging in wood products & mdf within the trade sector, it holds CIN: U24239MP2021PTC071972. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.85 M.

Employing 22 professional, Its leadership includes Isha Singh (Director), Neha Arora (Director), Damini Devlalikar (Director). Past directors included Pranay Kumar Singh, Akshay Devlalikar, Sonu Verma. It holds ₹5.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 6 Gulab Bagh Colony, Dewas Naka, Agrawal Bhawan, Indore, Madhya Pradesh, 452001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MP2021PTC071972

  • Registration Number

    071972

  • Incorporation Date

    08 February 2021

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.85 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.85 M
  • Company Age 5 Year, 1 Day
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 5.50 M
  • Revenue Growth **** 67.74%
  • Profit Growth **** -180.26%
  • Ebitda **** -0.27%
  • Net Worth 0.33%
  • Total Assets -12.56%
Company report

Sky Vision Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sky Vision Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sky Vision Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Isha Singh Director 07 Apr 2021 Current
Neha Arora Director 05 Apr 2021 Current
Damini Devlalikar Director 05 Apr 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 07 Apr 2021 Past
Pramod Abcsdd Director 05 Apr 2021 Past
Pramod Abcsdd Director 05 Apr 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sky Vision Pharma.

Sky Vision Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.74% increase. The company also saw a substantial fall in profitability, with a 180.26% decrease in profit. The company's net worth moved up by a moderate rise of 0.33%.

Sky Vision Pharma revenue growth over time
Sky Vision Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 67.74%
*******
*******
*******
*******
Revenue from Operations
*******
 67.74%
*******
*******
*******
*******
Total Assets
*******
 -12.56%
*******
*******
*******
*******
Profit or Loss
*******
 -180.26%
*******
*******
*******
*******
Net Worth
*******
 0.33%
*******
*******
*******
*******
EBITDA
*******
 -0.27%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sky Vision Pharma?

Unlock access to Sky Vision Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹5,500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 0.55 Cr
Latest Charge Details
Date Lender Amount Status
21 Nov 2022 State Bank Of India ₹5.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Sky Vision Pharma?

Sky Vision Pharma has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sky Vision Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sky Vision Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sky Vision Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sky Vision Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Sky Vision Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.

  • Charges

    The activity A charge with State Bank Of India amounted to Rs. 5.50 M with Charge ID 100656419 was registered on 21 Nov 2022. was completed.

  • Director Appointment

    Progress on Isha Singh was appointed as a Director was appointed as a Director on 07 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Director Appointment

    Progress on Neha Arora was appointed as a Director was appointed as a Director on 05 Apr 2021 & has been associated with this company since 4 years 10 months . was documented.

  • Director Appointment

    Damini Devlalikar was appointed as a Director was appointed as a Director on 05 Apr 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sky Vision Pharma Private Limited?

The CIN of Sky Vision Pharma Private Limited is U24239MP2021PTC071972.

Where is Sky Vision Pharma Private Limited headquartered?

Sky Vision Pharma Private Limited is headquartered at 6 Gulab Bagh Colony, Dewas Naka, Agrawal Bhawan, Indore, Madhya Pradesh, 452001.

When was Sky Vision Pharma Private Limited incorporated?

Sky Vision Pharma Private Limited was incorporated on 08 February 2021.

Who are the current directors of Sky Vision Pharma Private Limited?

The current directors of Sky Vision Pharma Private Limited are

What is the primary industry of Sky Vision Pharma Private Limited?

The primary industry of Sky Vision Pharma Private Limited is Trade.

Is Sky Vision Pharma Private Limited a listed company?

Sky Vision Pharma Private Limited is unlisted.

What is the capital structure of Sky Vision Pharma Private Limited?

The authorized capital of Sky Vision Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.85 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available